Kidney involvement in a nongenetic rat model of type 2 diabetes

Slides:



Advertisements
Similar presentations
Myoung J. Kang, Alistair Ingram, Hao Ly, Kerri Thai, James W. Scholey 
Advertisements

Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats  Alluru S. Reddi, Jaya S. Bollineni  Kidney International 
Volume 63, Issue 6, Pages (June 2003)
Volume 58, Issue 5, Pages (November 2000)
Volume 63, Issue 1, Pages (January 2003)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis  Y. Huang, W.A. Border, D.A. Lawrence, N.A.
Critical role for osteopontin in diabetic nephropathy
Volume 64, Issue 1, Pages (July 2003)
Volume 67, Issue 5, Pages (May 2005)
Volume 83, Issue 5, Pages (May 2013)
Volume 64, Issue 2, Pages (August 2003)
Volume 68, Issue 5, Pages (November 2005)
Volume 56, Issue 1, Pages (July 1999)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 58, Issue 6, Pages (December 2000)
Volume 66, Issue 6, Pages (December 2004)
Volume 67, Issue 3, Pages (March 2005)
Volume 63, Issue 6, Pages (June 2003)
Volume 61, Issue 5, Pages (May 2002)
Volume 69, Issue 1, Pages (January 2006)
Volume 68, Issue 1, Pages (July 2005)
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 4, Pages (April 2001)
Volume 87, Issue 2, Pages (February 2015)
Volume 64, Issue 2, Pages (August 2003)
Volume 68, Issue 4, Pages (October 2005)
Volume 73, Issue 4, Pages (February 2008)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 87, Issue 2, Pages (February 2015)
Volume 63, Issue 2, Pages (February 2003)
Insulin resistance in African Americans
Volume 67, Issue 2, Pages (February 2005)
Volume 62, Issue 3, Pages (September 2002)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
The role of protein kinase C activation in diabetic nephropathy
Volume 79, Issue 10, Pages (May 2011)
Volume 56, Issue 5, Pages (November 1999)
Volume 79, Issue 4, Pages (February 2011)
Volume 68, Issue 1, Pages (July 2005)
Volume 62, Issue 3, Pages (September 2002)
Volume 72, Issue 12, Pages (December 2007)
Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.
Volume 63, Issue 1, Pages (January 2003)
Volume 67, Issue 2, Pages (February 2005)
Volume 85, Issue 2, Pages (January 2014)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 73, Issue 6, Pages (March 2008)
Volume 66, Issue 4, Pages (October 2004)
Volume 59, Issue 4, Pages (April 2001)
Volume 66, Issue 5, Pages (November 2004)
Volume 82, Issue 3, Pages (August 2012)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
Volume 60, Issue 5, Pages (November 2001)
Volume 69, Issue 7, Pages (April 2006)
Volume 67, Issue 6, Pages (June 2005)
Volume 58, Issue 3, Pages (September 2000)
The course of the remnant kidney model in mice
Volume 61, Issue 3, Pages (March 2002)
Volume 58, Issue 5, Pages (November 2000)
Volume 58, Issue 3, Pages (September 2000)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Increased renal calcium and magnesium transporter abundance in streptozotocin- induced diabetes mellitus  C-T. Lee, Y-H.H. Lien, L-W. Lai, J-B. Chen, C-R.
Effect of prenatal dexamethasone on rat renal development
Volume 61, Issue 1, Pages (January 2002)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Volume 70, Issue 1, Pages (July 2006)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Kidney involvement in a nongenetic rat model of type 2 diabetes Ratna S. Danda, Nusrath M. Habiba, Hernan Rincon-Choles, Basant K. Bhandari, Jeffrey L. Barnes, Hanna E. Abboud, Pablo E. Pergola  Kidney International  Volume 68, Issue 6, Pages 2562-2571 (December 2005) DOI: 10.1111/j.1523-1755.2005.00727.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Blood glucose levels (mg/dL) obtained by tail vein puncture during the study period at 2-week intervals. Rats with diabetes had elevated blood glucose levels throughout the study compared to control and high fat diet groups. High fat diet alone did not cause hyperglycemia. DM is diabetes mellitus and STZ is streptozotocin. Data are mean ± SE. *P < 0.05 vs. control;†P < 0.05 vs. high fat diet;‡P < 0.05 vs. type 1 diabetes. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Body weight (g) at weekly intervals starting 4 weeks prior to the end of the study period. Data are mean ± SE. High fat diet rats were heavier than controls throughout the study period. Type 2 diabetes mellitus (DM) rats lost less weight than type 1 diabetes mellitus rats by the end of the study period. STZ is streptozotocin. *P < 0.05 vs. control;†P < 0.05 vs. high fat diet;‡P < 0.05 vs. type 1 diabetes mellitus. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Urinary protein excretion (mg protein/mg creatinine). Data are mean ± SE. Type 1 diabetes mellitus (DM) rats had significantly higher proteinuria compared to type 2 diabetes mellitus rats. The high fat diet group did not develop proteinuria by the end of the study period. STZ is streptozotocin. *P < 0.05 vs. control;†P < 0.05 vs. high fat diet;‡P < 0.05 vs. type 1 diabetes mellitus. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Systolic blood pressure (mm Hg) measured by noninvasive tail cuff plethysmography at 2-week interval during the study period. Data are mean ± SE. Systolic blood pressure in type 2 diabetes mellitus (DM) group was higher at baseline compared to high fat diet since rats were randomized based on their body weight and not their blood pressure. Systolic blood pressure was high in all experimental groups compared to control at the end of the study. There was no difference in systolic blood pressure between high fat diet, type 1 and type 2 diabetes mellitus groups at the end of the study period. *P < 0.05 vs. control;†P < 0.05 vs. high fat diet;‡P < 0.05 vs. type 1 diabetes mellitus. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Histology [Jones periodic acid-Schiff stain (PAS)] of representative glomeruli at 20× magnification from control, high fat diet, type 1 and 2 diabetes mellitus (DM) groups 14 weeks postinduction of diabetes. Jones PAS-stained glomeruli showed expanded mesangium in all experimental groups relative to control. Type 2 diabetic animals were most affected, showing substantially more widening of matrix than type 1 diabets or high fat diet. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Immunohistochemical staining of glomeruli for cellular fibronectin in frozen kidney sections (20× magnification, upper three panels). Quantification of the% glomerular fibronectin stain area is shown in the lower panel. Fibronectin stain area was greater in both diabetes mellitus (DM) groups compared to control but greatest in the type 2 diabetic group. Data are not available for the high fat diet group because tissue was unsuitable for histochemistry due to technical problems (related to the processing of the tissue). *P < 0.05 vs. control;‡P < 0.05 vs. type 1 diabetes mellitus. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Immunoblot analysis of fibronectin and type IV collagen. Data are mean ± SE. Fibronectin expression in whole kidney lysates was significantly increased in all three groups compared to controls. Type IV collagen was increased only in high fat diet (HFD) and type 2 diabetes mellitus (DM) groups. *P < 0.05 vs. control. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Immunoblot analysis for transforming growth factor-β (TGF-β) and connective tissue growth factor (CTGF). Data are mean ± SE. TGF-β and CTGF expression in whole kidney lysates was significantly increased only in high fat diet (HFD) and type 2 diabetes mellitus (DM) groups. *P < 0.05 vs. control. Kidney International 2005 68, 2562-2571DOI: (10.1111/j.1523-1755.2005.00727.x) Copyright © 2005 International Society of Nephrology Terms and Conditions